Skip to content

EVOFEM BIOSCIENCES, INC.: 10-Q filed 2016-08-11

What EVOFEM BIOSCIENCES, INC. reported in its quarterly report filed 2016-08-11 (fiscal Q2 2016): 19 published measures, 49 facts as tagged in accession 0001564590-16-023997.

This filing

Form
10-Q (quarterly report)
Filed
2016-08-11
Fiscal period
fiscal Q2 2016
Accession
0001564590-16-023997 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All EVOFEM BIOSCIENCES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-06-3022,580,428USD
At 2015-12-3140,111,972USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-06-3016,038,555USD
At 2015-12-3123,807,295USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2016-06-3021,471,803USD
At 2015-12-3137,748,603USD
At 2015-06-3062,954,955USD
At 2014-12-3175,947,516USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-2,657,489USD91
2016-01-01 to 2016-06-30-8,684,045USD182
2015-04-01 to 2015-06-30-9,477,430USD91
2015-01-01 to 2015-06-30-16,379,810USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2015-01-01 to 2015-06-30226,128USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-06-30-121,515,802USD
At 2015-12-31-112,831,757USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2016-06-30150,948USD
At 2015-12-31186,372USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2016-01-01 to 2016-06-30887,363USD182
2015-01-01 to 2015-06-30676,028USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-2,519,838USD91
2016-01-01 to 2016-06-30-8,301,007USD182
2015-04-01 to 2015-06-30-9,199,215USD91
2015-01-01 to 2015-06-30-15,837,204USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2016-06-3022,229,480USD
At 2015-12-3139,725,600USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2016-06-303,732,272USD
At 2015-12-319,099,501USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2016-06-301,090,119USD
At 2015-12-314,017,192USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2016-04-01 to 2016-06-302,519,838USD91
2016-01-01 to 2016-06-308,301,007USD182
2015-04-01 to 2015-06-309,199,215USD91
2015-01-01 to 2015-06-3015,837,204USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2016-04-01 to 2016-06-301,428,196USD91
2016-01-01 to 2016-06-304,688,494USD182
2015-04-01 to 2015-06-307,469,928USD91
2015-01-01 to 2015-06-3012,170,596USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2016-06-3013,815,589shares
At 2015-12-3113,750,016shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2016-06-30279,547USD
At 2015-12-31279,547USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2016-06-30128,599USD
At 2015-12-3193,175USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2016-06-30757,677USD
At 2015-12-311,976,997USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2016-04-01 to 2016-06-301,091,642USD91
2016-01-01 to 2016-06-303,612,513USD182
2015-04-01 to 2015-06-301,729,287USD91
2015-01-01 to 2015-06-303,666,608USD181

Inspect the source

Entity
EVOFEM BIOSCIENCES, INC. / CIK 0001618835
Captured
2026-09-21T17:21:39.444Z
SEC response SHA-256
c8bf3bae341cb8de34e01a708b32050739ddc460f13010d7d1bd9abd1c4dd597

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001618835.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))